These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3220104)

  • 1. Human IgG and IgA subclass response following immunization with a polyvalent Klebsiella capsular polysaccharide vaccine.
    Cryz SJ; Cross AS; Sadoff GC; Que JU
    Eur J Immunol; 1988 Dec; 18(12):2073-5. PubMed ID: 3220104
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunization of humans with polysaccharide vaccines induces systemic, predominantly polymeric IgA2-subclass antibody responses.
    Tarkowski A; Lue C; Moldoveanu Z; Kiyono H; McGhee JR; Mestecky J
    J Immunol; 1990 May; 144(10):3770-8. PubMed ID: 2110213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the human immune response to a Pseudomonas aeruginosa O-polysaccharide-toxin A conjugate vaccine.
    Cryz SJ; Sadoff JC; Ohman D; Fürer E
    J Lab Clin Med; 1988 Jun; 111(6):701-7. PubMed ID: 3131471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced IgG1 and IgG3 responses to pneumococcal polysaccharides in isolated IgA deficiency.
    Roberton DM; Björkander J; Henrichsen J; Söderström T; Hanson LA
    Clin Exp Immunol; 1989 Feb; 75(2):201-5. PubMed ID: 2702775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic immunization with pneumococcal polysaccharide vaccine induces a predominant IgA2 response of peripheral blood lymphocytes and increases of both serum and secretory anti-pneumococcal antibodies.
    Lue C; Tarkowski A; Mestecky J
    J Immunol; 1988 Jun; 140(11):3793-800. PubMed ID: 3372993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evolution of the subclass of IgG antibody to type 3 pneumococcal polysaccharide during childhood.
    Schatz DA; Barrett DJ
    Clin Exp Immunol; 1987 Nov; 70(2):449-55. PubMed ID: 3427829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IgG subclass deficiencies and recurrent pyogenic infections, unresponsiveness against bacterial polysaccharide antigens.
    Kuijpers TW; Weening RS; Out TA
    Allergol Immunopathol (Madr); 1992; 20(1):28-34. PubMed ID: 1509985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gamma 3 gene-disrupted mice selectively deficient in the dominant IgG subclass made to bacterial polysaccharides undergo normal isotype switching after immunization with polysaccharide-protein conjugate vaccines.
    Shapiro DA; Threadgill DS; Copfer MJ; Corey DA; McCool TL; McCormick LL; Magnuson TR; Greenspan NS; Schreiber JR
    J Immunol; 1998 Oct; 161(7):3393-9. PubMed ID: 9759856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subclass distribution of human antibodies to Haemophilus influenzae type b capsular polysaccharide.
    Shackelford PG; Granoff DM; Nelson SJ; Scott MG; Smith DS; Nahm MH
    J Immunol; 1987 Jan; 138(2):587-92. PubMed ID: 3491852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IgG subclasses and avidity of antibodies to polysaccharide antigens in allogeneic BMT recipients after vaccination with pneumococcal polysaccharide and Haemophilus influenzae type b conjugate vaccines.
    Parkkali T; Käyhty H; Anttila M; Ruutu T; Wuorimaa T; Soininen A; Volin L; Ruutu P
    Bone Marrow Transplant; 1999 Sep; 24(6):671-8. PubMed ID: 10490735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isotype concentrations of human antibodies to Haemophilus influenzae type b polysaccharide (Hib) in young adults immunized with the polysaccharide as such or conjugated to a protein (diphtheria toxoid).
    Mäkelä O; Mattila P; Rautonen N; Seppälä I; Eskola J; Käyhty H
    J Immunol; 1987 Sep; 139(6):1999-2004. PubMed ID: 3497985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pneumococcal conjugate vaccine primes for polysaccharide-inducible IgG2 antibody response in children with recurrent otitis media acuta.
    Breukels MA; Rijkers GT; Voorhorst-Ogink MM; Zegers BJ; Sanders LA
    J Infect Dis; 1999 May; 179(5):1152-6. PubMed ID: 10191217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IgG2 subclass restriction of antibody to pneumococcal polysaccharides.
    Barrett DJ; Ayoub EM
    Clin Exp Immunol; 1986 Jan; 63(1):127-34. PubMed ID: 3955880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional activity of different IgG subclass antibodies against type b capsular polysaccharide of Haemophilus influenzae.
    Weinberg GA; Granoff DM; Nahm MH; Shackelford PG
    J Immunol; 1986 Jun; 136(11):4232-6. PubMed ID: 3486228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isotype concentrations of human antibodies to group A meningococcal polysaccharide.
    Rautonen N; Pelkonen J; Sipinen S; Käyhty H; Mäkelä O
    J Immunol; 1986 Oct; 137(8):2670-5. PubMed ID: 3093581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and immunogenicity of a polyvalent Klebsiella capsular polysaccharide vaccine in humans.
    Cryz SJ; Mortimer P; Cross AS; Fürer E; Germanier R
    Vaccine; 1986 Mar; 4(1):15-20. PubMed ID: 3962447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of human IgG and IgA subclass antibody-secreting cells from localized chronic inflammatory tissue.
    Ogawa T; Tarkowski A; McGhee ML; Moldoveanu Z; Mestecky J; Hirsch HZ; Koopman WJ; Hamada S; McGhee JR; Kiyono H
    J Immunol; 1989 Feb; 142(4):1150-8. PubMed ID: 2644350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody response to pneumococcal vaccine in splenectomized children.
    Pedersen FK
    Acta Pathol Microbiol Immunol Scand C; 1983 Apr; 91(2):169-80. PubMed ID: 6880749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effect of human immunodeficiency virus infection on the IgA and IgG antibody responses to pneumococcal vaccine.
    Mascart-Lemone F; Gérard M; Libin M; Crusiaux A; Franchioly P; Lambrechts A; Goldman M; Clumeck N
    J Infect Dis; 1995 Nov; 172(5):1253-60. PubMed ID: 7594661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune status and response to immunization with polysaccharide vaccines of a healthy, congenitally asplenic woman.
    McElroy PJ; Henderson FI; Brown DL
    Clin Exp Immunol; 1989 Dec; 78(3):402-5. PubMed ID: 2612052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.